A FOUR-YEAR EXPERIENCE WITH TOTAL-BODY IRRADIATION.
Explore the source record for details and available documents.
Humans↗
Biomedical subjects
M L JACOBS
Publications and source records attributed to M L JACOBS.
LYMPHOMAS: RELATIONSHIP BETWEEN DOSAGE AND RECURRENCE.
Explore the source record for details and available documents.
Hodgkin Disease↗
Comparison between the one-stage prothrombin time and factor VII and X complex determination in bishydroxycoumarin-induced hypoprothrombinemia countered by phytonadione.
Explore the source record for details and available documents.
Blood Coagulation Tests↗
Highenergy radiography (cobalt 60 and cesium 137) for tumor localization and treatment planning.
Explore the source record for details and available documents.
Cesium↗
Dosimetry for a total-body irradiation chamber.
Explore the source record for details and available documents.
Humans↗
A total body irradiation chamber and its uses.
Explore the source record for details and available documents.
Equipment and Supplies↗
Radioactive colloidal chromic phosphate to control pleural effusion and ascites.
Explore the source record for details and available documents.
Ascites↗
Radiological therapy of carcinoma of the lung.
Explore the source record for details and available documents.
Carcinoma↗
Use of radioactive chromic phosphate in pleural effusions.
Radioactive chromic phosphate was chosen in place of radioactive gold for control of pleural effusions and ascites. The chromic phosphate has no gamma radiation to complicate the health physics. Its 14.3 day half-life in contrast to that of 2.69 days for gold makes possible the use of much smaller total dosages. There were no untoward results from the use of this material. The results in the series here reported upon compare favorably with those reported for gold(198).
Ascites↗